Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Dominique Caparros-Lefebvre »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dominique Bonneau < Dominique Caparros-Lefebvre < Dominique Cardebat  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000264 (2009) Dominique Caparros-Lefebvre [France] ; Olivier Kerdraon [France] ; David Devos [France] ; C. M. Dhaenens [France] ; David Blum [France] ; C. A Maurage [France] ; André Delacourte [France] ; Bernard Sablonnière [France]Association of corticobasal degeneration and Huntington's disease: Can Tau aggregates protect Huntingtin toxicity?
000365 (2006) Dominique Caparros-Lefebvre [France] ; John Steele [États-Unis] ; Yaichiro Kotake [Japon] ; Shigeru Ohta [Japon]Geographic isolates of atypical Parkinsonism and tauopathy in the tropics: Possible synergy of neurotoxins
000388 (2006) Dominique Caparros-Lefebvre [France] ; John Steele [États-Unis] ; Yaichiro Kotake [Japon] ; Shigeru Ohta [Japon]Geographic isolates of atypical parkinsonism and tauopathy in the tropics : Possible synergy of neurotoxins
000416 (2005) Dominique Caparros-Lefebvre [France] ; Andrew Lees (neurologue) [Royaume-Uni]Atypical unclassifiable parkinsonism on Guadeloupe: An environmental toxic hypothesis
000422 (2005) Dominique Caparros-Lefebvre [France] ; Andrew Lees (neurologue) [Royaume-Uni]Atypical unclassifiable parkinsonism on guadeloupe : An environmental toxic hypothesis
000439 (2004) Dominique Caparros-Lefebvre [France]Atypical parkinsonism in New Caledonia: Comparison with Guadeloupe and association with Annonaceae consumption
000465 (2002) Annie Lannuzel [France] ; Patrick P. Michel [France] ; Dominique Caparros-Lefebvre [France] ; Jacqueline Abaul ; Reynald Hocquemiller ; Merle Ruberg [France]Toxicity of Annonaceae for dopaminergic neurons: Potential role in atypical parkinsonism in Guadeloupe
000489 (2002) Annie Lannuzel [France] ; Cécile Hermann [France] ; Chérine Yousry [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Dominique Caparros-Lefebvre [France]Encephalomyelitis with rigidity complicating human immunodeficiency virus infection
000509 (2001) Dennis W. Dickson [États-Unis] ; Brian Anderton [Royaume-Uni] ; Huw Morris [Royaume-Uni] ; John Hodges [Royaume-Uni] ; Thomas H. Bak [Royaume-Uni] ; B. Dubois [France] ; B. Pillon [France] ; T. Bak [France] ; R. Rafal [France] ; J. Grafman [France] ; Lawrence I. Golbe [États-Unis] ; John Steele [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Marie Vidailhet [France] ; S. Rivaud-Pechoux [France] ; Irene Livan [États-Unis] ; Charles Pierrot-Deseilligny [France] ; Clare J. Fowler [Royaume-Uni] ; Timothy Lynch [Irlande (pays)] ; Catherine Bergeron [Canada] ; Kailash Bhatia [Royaume-Uni] ; Martin N. Rossor [Royaume-Uni] ; Gregor K. Wenning [États-Unis, Royaume-Uni, France, Irlande (pays), Canada, Allemagne] ; Christopher J. Mathias [Royaume-Uni] ; Thomas Klockgether [Allemagne] ; M. Abele [Allemagne] ; U. Wullner [Allemagne] ; Peter Lantos [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Dominique Caparros-Lefebvre [France]International Medical Workshop covering progressive supranuclear palsy, multiple system atrophy and cortico basal degeneration
000540 (1999) Dominique Caparros-Lefebvre [France] ; Annie Lannuzel [France] ; François Tiberghien [France] ; Michel Strobel [France]Protease inhibitors enhance levodopa effects in Parkinson's disease

List of associated KwdEn.i

Nombre de
documents
Descripteur
6Humans
5Guadeloupe
3Parkinsonism
2Adult
2Aged
2Annonaceae (adverse effects)
2Female
2Guadeloupe (epidemiology)
2Guam
2Male
2Nervous system diseases
2Parkinsonian Disorders (epidemiology)
1AIDS
1Acetogenins
1Amino Acids, Diamino (toxicity)
1Annonaceae
1Annonaceae (toxicity)
1Anticonvulsants (therapeutic use)
1Antiparkinson Agents (antagonists & inhibitors)
1Antiparkinson Agents (therapeutic use)
1Apoptosis (drug effects)
1Atypical
1Basal Ganglia (pathology)
1Case study
1Cell Culture Techniques
1Cell culture
1Cerebral Cortex (pathology)
1Clonazepam (therapeutic use)
1Complication
1Dopamine (metabolism)
1Dopamine Plasma Membrane Transport Proteins
1Dopaminergic neuron
1Drug Resistance
1Drug Synergism
1Electromyography
1Encephalomyelitis
1Encephalomyelitis (diagnosis)
1Encephalomyelitis (etiology)
1Environmental Exposure (adverse effects)
1Epstein Barr virus
1Epstein-Barr Virus Infections (complications)
1Etiology
1Fatty Alcohols (toxicity)
1Gabaergic neuron
1HIV Infections (complications)
1HIV-1 virus
1Human
1Huntington Disease (complications)
1Huntington Disease (metabolism)
1Huntington Disease (pathology)
1Immunohistochemistry
1Japan
1Lactones (toxicity)
1Levodopa (antagonists & inhibitors)
1Levodopa (therapeutic use)
1Membrane Glycoproteins
1Membrane Transport Proteins (drug effects)
1Mesencephalon (drug effects)
1Mesencephalon (pathology)
1Middle Aged
1Motor Neuron Disease (chemically induced)
1Motor Neuron Disease (epidemiology)
1Muscle Rigidity (diagnosis)
1Muscle Rigidity (drug therapy)
1Muscle Rigidity (etiology)
1Nerve Tissue Proteins
1Nerve Tissue Proteins (metabolism)
1Neurodegenerative Diseases (complications)
1Neurodegenerative Diseases (metabolism)
1Neurodegenerative Diseases (pathology)
1Neurons (drug effects)
1Neurons (metabolism)
1Neuropsychological Tests
1Neurotoxin
1Neurotoxins (toxicity)
1Nuclear Proteins (metabolism)
1Pacific Islands
1Parkinson Disease (ethnology)
1Parkinson Disease (etiology)
1Parkinson Disease, Secondary (chemically induced)
1Parkinson Disease, Secondary (epidemiology)
1Parkinsonian Disorders (classification)
1Parkinsonian Disorders (drug therapy)
1Parkinsonian Disorders (etiology)
1Prognosis
1Rotenone (toxicity)
1Severity of Illness Index
1Spasticity
1Tauopathies (chemically induced)
1Toxicity
1Tropical Climate
1Videotape Recording
1West
1West Indies
1annonaceae acetogenins
1apoptosis
1atypical Parkinsonism
1atypical parkinsonism
1movement disorders
1neurotoxicology

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Dominique Caparros-Lefebvre" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Dominique Caparros-Lefebvre" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Dominique Caparros-Lefebvre
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024